LBBAP using the INGEVITY+ lead was successfully achieved in 97% of cases, with no lead fractures and stable electrical performance during 9 months follow-up.
Does left bundle branch area pacing using an active fixation stylet-driven lead provide comparable safety and electrical performance to standard right ventricular pacing?
Left bundle branch area pacing using a conventional stylet-driven lead is highly successful (97%) and demonstrates comparable mid-term safety and electrical stability to standard right ventricular pacing.
Absolute Event Rate: 0% vs 0%
ABSTRACT Background Left bundle branch area pacing (LBBAP) has emerged as a promising physiological pacing strategy. However, its feasibility and safety using conventional stylet‐driven leads (SDL) such as INGEVITY+ remain under investigation. Objective To evaluate the clinical performance, safety, and follow‐up outcomes of LBBAP using the INGEVITY+ lead in a real‐world electrophysiology setting. Methods From 2021 to 2024, 207 consecutive patients underwent LBBAP implant attempts using the INGEVITY+ lead across 19 centers. Of these, 146 had bradycardia indications, and 61 had heart failure indications. A control group of 200 patients received standard right ventricular (RV) pacing with the same lead. Procedural outcomes, electrical parameters, complications, and mid‐term lead performance were assessed. Results LBBAP was successfully achieved in 201 (97%) cases. Procedural and fluoroscopy times were slightly longer for LBBAP than for RV pacing. Acute complications included one helix fracture, one atrioventricular block, and one septal perforation. During a median follow‐up of 9 months, no lead fractures were reported; lead dislodgment occurred in three cases. Kaplan–Meier analysis showed no significant difference in time to first lead‐related complication between the LBBAP and RV pacing groups (hazard ratio: 4.69, 95%CI: 0.63–34.90, p = 0.139). Electrical performance remained stable, with 98% of retained leads maintaining capture thresholds ≤ 2 V and 92% with sensed amplitudes ≥ 5 mV. Conclusions LBBAP using the INGEVITY + SDL is feasible and safe in clinical practice, with excellent implant success and stable mid‐term electrical performance. These findings support its use as a viable conduction system pacing strategy.
Santoro et al. (Sat,) reported a other. LBBAP using the INGEVITY+ lead was successfully achieved in 97% of cases, with no lead fractures and stable electrical performance during 9 months follow-up.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: